The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control

Affiliations

¹ Northern Institute of Cancer Research, Academic Haematology, Medical School, Newcastle University. Electronic address: s.j.proctor@ncl.ac.uk.
² Department of Haematology.
³ Northern Centre for Cancer Treatment, Newcastle NHS Hospital Foundation Trust.
⁴ Institute of Health and Society, Newcastle University.
⁵ Scotland and Newcastle Lymphoma Group, Academic Haematology, Medical School, Newcastle University, Newcastle upon Tyne.
⁶ Northern Institute of Cancer Research, Academic Haematology, Medical School, Newcastle University.
⁷ Department of Haematology, Gartnavel General Hospital, Glasgow.
⁸ Department of Haematology, Ward 16, Anchor Unit, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, UK.

Free article

Review

S J Proctor et al. Ann Oncol. 2010 Feb.

Free article

. 2010 Feb;21(2):426-428.

doi: 10.1093/annonc/mdp527. Epub 2009 Nov 9.

¹ Northern Institute of Cancer Research, Academic Haematology, Medical School, Newcastle University. Electronic address: s.j.proctor@ncl.ac.uk.
² Department of Haematology.
³ Northern Centre for Cancer Treatment, Newcastle NHS Hospital Foundation Trust.
⁴ Institute of Health and Society, Newcastle University.
⁵ Scotland and Newcastle Lymphoma Group, Academic Haematology, Medical School, Newcastle University, Newcastle upon Tyne.
⁶ Northern Institute of Cancer Research, Academic Haematology, Medical School, Newcastle University.
⁷ Department of Haematology, Gartnavel General Hospital, Glasgow.
⁸ Department of Haematology, Ward 16, Anchor Unit, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, UK.

No abstract available

Publication types